Hallucinations in Psychoses and Affective Disorders A Clinical and B
This book presents state of the art knowledge on the psychopathology, clinical symptomatology, biology, and treatment of hallucinations in patients with psychoses and affective disorders. The opening section describes and examines the origins of the hallu
- PDF / 3,879,890 Bytes
- 210 Pages / 439.42 x 683.15 pts Page_size
- 46 Downloads / 173 Views
123
Hallucinations in Psychoses and Affective Disorders
Paolo Brambilla • Massimo Carlo Mauri Alfredo Carlo Altamura Editors
Hallucinations in Psychoses and Affective Disorders A Clinical and Biological Approach
Editors Paolo Brambilla Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico University of Milan Milan Italy
Massimo Carlo Mauri Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico University of Milan Milan Italy
Alfredo Carlo Altamura Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico University of Milan Milan Italy
ISBN 978-3-319-75123-8 ISBN 978-3-319-75124-5 (eBook) https://doi.org/10.1007/978-3-319-75124-5 Library of Congress Control Number: 2018947582 © Springer International Publishing AG, part of Springer Nature 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Presentation
Of all patients diagnosed with schizophrenia or related psychotic disorders, 60–80% experience auditory hallucinations and a smaller proportion visual or other unimodal hallucinations. Hallucinations can be dramatic and may have severe impact in affected individuals, and it might be associated with suicidality, violence, and sometimes homicide. Currently, the abuse of substances with psychotomimetic properties, such as cocaine, amphetamines, hallucinogens, ketamine and cannabis, represents one of the main causes of hallucinogen perception disorders. Indeed, the use or the abuse of these substances can result in psychotic reactions, including hallucinations, and can therefore resemble a primary psychotic disorder. In general, the use of drugs has increased during early adolescence, when the developing brain might be especially sensitive to envir
Data Loading...
